Bernd Schulte, Dipl. Public Health

wissenschaftlicher Mitarbeiter

Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg

Martinistraße 52
20246 Hamburg

Tel. 0049 40 / 7410-59438

Fax 0049 40 / 7410-58351
eMail: b.schulte@uke.de

Lebenslauf

seit 2011wissenschaftlicher Mitarbeiter am Zentrum für Interdisziplinäre Suchtforschung, Universität Hamburg
2009-2011  Resident Twinning Advisor, Institut für Therapieforschung, München
2003-2009wissenschaftlicher Mitarbeiter am Zentrum für Interdisziplinäre Suchtforschung, Universität Hamburg
bis 2003Public Health Studium HAW Hamburg, Schwerpunkt Epidemiologie und klinische Psychologie

Interessensschwerpunkt

  • Versorgungs- und Implementierungsforschung
  • Infektionsepidemiologie
  • Public Health

Projekte

Publikationen

Originalarbeiten

  • Fraser H, Martin NK, Brummer-Korvenkontio H, CarrieriP, Dalgard O, Dillon J, Goldberg D, Hutchinson S, Jauffret-Roustide M, Kåberg M, Matser AA, Mati?i? M, Midgard H, Mravcik V, Øvrehus A, Prins M, Reimer J, Robaeys R, Schulte B, van Santen DK, Zimmermann R, Vickerman P, Hickman M (2017) Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of hepatology, DOI: 10.1016/j.jhep.2017.10.010
  • Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C, Burton R, Cardoso M, Colom J, Duprez D, Gmel G, Gual A, Kraus L,
    Kreutz R, Liira H, Manthey J, Møller L, Okruhlica ?, Roerecke M, Scafato E, Schulte B, Segura-Garcia L, Shield KD, Sierra C, Vyshinskiy K, Wojnar M, Zarco J. (2017)
    Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med. 28;15:173. doi:
    10.1186/s12916-017-0934-1
  • Grundmann J, Lincoln TM, Lüdecke D, Bong S, Schulte B, Verthein U, Schäfer I (2017) Traumatic Experiences, Revictimization and Posttraumatic Stress Disorder in German Inpatients Treated for Alcohol Dependence. Substance Use & Misuse http://dx.doi.org/10.1080/10826084.2017.1361997
  • Strada L, Vanderplasschen W, Buchholz A,  Schulte B, Muller AE, Verthein U, Reimer J. (2017) Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments. Qual Life Res. https://doi.org/10.1007/s11136-017-1674-6
  • Anderson P, O'Donnell A, Kaner E, Gual A, Schulte B, Perez-Gomez A, deVries H, Natera G, Rehm J (2017) Scaling-up primary health care-based prevention and management of alcohol use disorder at the municipal level in middle-income countries in Latin America: Background and pre-protocol for a three-country quasi-experimental study. F1000Research 2017, 6:311 (doi: 10.12688/f1000research.11173.1)
  • Kraus L, Schulte B, Manthey J, Rehm J (2016): Alcohol screening and alcohol interventions among patients with hypertension in primary health care: an empirical survey of German general practitioners. Addiction Research & Theory: 25:4, 285-92.
  • Rehm J, Prieto J, Beier M, Duhot D, Rossi A, Schulte B, Zarco J, Aubin HJ, Bachmann M, Grimm C, Kraus L, Manthey J, Scafato E, Gua A. (2016) The role of alcohol in the management of hypertension in patients in European primary health care practices - A survey in the largest European Union countries. BMC Family Practice 17(1); DOI: 10.1186/s12875-016-0529-5
  • Kraus L, Hay G, Richardson C, Yargic I, Ilhan M, Ay P, Karasahin F, Pinarci M, Tuncoglu T, Piontek D and Schulte B (2016) Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir. Drug and Alcohol Review, doi: 10.1111/dar.12447
  • Schmidt CS, Schulte B, Seo HN, Kuhn S, O Donnell A, Kriston L, Verthein U, Reimer J. (2016). Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction. 2015 Dec 5. doi: 10.1111/add.13263
  • Schulte B, Schmidt CS, Strada L, Götzke C, Hiller P, Fischer B, Reimer J (2016). Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users. Int J Drug Pol doi:10.1016/j.drugpo.2015.12.024
  • Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Kru?ckeberg S, Reimer J (2015) Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): Study protocol. BMC Infectious Diseases (2015) 15:563 DOI 10.1186/s12879-015-1307-z
  • O’Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Kaner E. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcoholism 2014; 49: 66-78.
  • Schmidt CS, McGovern R, Schulte B, O'Donnell A, Lehmann K, Kuhn S, Schäfer I, Newbury-Birch D, Anderson P, Kaner E, Reimer J. Brief Alcohol Interventions in Social Service and Criminal Justice Settings: A Critical Commentary. Br J Soc Work 2014 doi: 10.1093/bjsw/bcu100
  • Schulte B, O`Donnell A, Kastner S, Schmidt CS, Schäfer I, Reimer J. Alcohol screening and brief intervention in workplace settings and social services: A comparison of literature. Front. Psychiatry 2014 doi: 10.3389/fpsyt.2014.00131
  • Schäfer I, Gromus L, Atabaki A, Pawlis S, Verthein U, Reimer J, Schulte B, Martens M. Are experiences of sexual violence related to special needs in patients with substance use disorders? A study in opioid-dependent patients. Addictive Behaviors 2014: 39; 1691–94
  • Mravcik V, Strada L, Reimer J, Schulte B. Hepatitis C treatment uptake and adherence among injecting drug users in the Czech Republic. Epidemiologie, mikrobiologie, imunologie. 2014 Fall;63(4):265-269
  • Schulte B, Gonzales-Saiz F, Jeschke P, Reimer J, Schäfer I, Walcher S, Weber B, Verthein U. Die Opiate-Dosage-Adequacy-Scale (ODAS) für die Beurteilung der Angemessenheit der Buprenorphindosierung während der Opiatsubstitution. Suchttherapie 2014; 15: 35-42.
  • Schmidt CS, Schön D, Schulte B, Lüth S, Polywka S, Reimer J. Viral hepatitis in alcohol-dependent inpatients – Prevalence, risk factors and treatment uptake. Journal of Addiction Medicine 2013; 7:417-21. doi: 10.1097/ADM.0b013e3182a50817
  • Mravcík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B. Factors associated with the uptake, adherence and efficacy of hepatitis C treatment among people who inject drugs: a literature review. Patient Preference and Adherence 2013; 7:1067-1075
  • Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M. Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.
  • Schulte B, Schmidt CS, Schäfer I, Fischer B, Wedemeyer H, ReimerJ. Structural barriers in the context of opiate substitution treatment in Germany. Substance Abuse, Treatment, Prevention & Policy 2013; 8:26
  • Schulte B, Schmidt CS, Milin S, Farnbacher G, Schäfer I, Hillemacher T, Kiefer F, Bleich S, Reimer J (2013) Barrieren und Möglichkeiten in der Umsetzung von alkoholbezogenen Interventionen in der hausärztlichen Praxis. Suchttherapie 2014; 15: 35-42.
  • Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M.  Psychoeducation improves hepatitis C virus therapy outcomes in opioid-substituted patients: A controlled, prospective multicentre trial. Clinical infectious diseases 2013; 57 Suppl 2: 97-S104.
  • O’Donnell A, Kaner E, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Anderson P. Efficacious, effective but still erratic: what will it take to get routine delivery of brief interventions for alcohol in primary healthcare settings? Alcohol & Alcoholism 2013; 49 doi:10.1093/alcalc/agt170
  • Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J. Non-prescribed use of substitution medication among German drug users – Prevalence, motives and availability. International Journal of Drug Policy,  2013;24:e111-4. doi:10.1016/j.drugpo.2013.04.006
  • Mravcík V, Škacupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173 Abstract
  • Mravcík V, Škarupová K, Orlíková B, Zábranský T, Karachaliou K, Schulte B (2011) Use of gelatine capsules for application of methamphetamine: A new harm reduction approach. Int J Drug Policy 22, 172-173
  • Schulte B, Schütt S, Brack J, Isernhagen K, Deibler P, Dilg C, Verthein U, Haasen C. Reimer J (2010). Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance. Drug and Alcohol Dependence 109: 248-251
  • Keppler K, Stöver H, Schulte B, Reimer J (2010). Prison health is public health! Problems in adapting and implementing health services for prisoners in Germany.  Bundesgesundheitsblatt 53, 233–244
  • Schulte B, Gansefort D, Stöver H, Reimer J. Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung Opiatabhängiger. Suchttherapie 2009; 10; 125-130.
  • Haasen C, Schulte B, Vanderplasschen W, Verthein U, Schäfer I, Reimer J: Predictive value of regular cocaine use among opioid-dependent patients for long-term outcome. Addictive Disorders & Their Treatment, 2009; 8:74-79
  • Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV- / HIV-infection in a sample of 31 German prisons for sentenced inmates. International Journal of Prisoner Health 2009; 5: 38-44.
  • Schulte B, Stöver H, Thane K, Schreiter C, Gansefort D, Reimer J. Substitution treatment and HCV- / HIV-infection in a sample of 31 German prisons for sentenced inmates. International Journal of Prisoner Health 2009; 5: 38-44.
  • Reimer J, Schulte B, Castells X, Schaefer I, Polywka S, Hedrich D, Wiessing L Haasen C, Backmund M, Krausz M (2005). Guidelines for treatment of hepatitis C virus infection in injecting drug users: status quo in the European Union countries. Clinical Infectious Diseases; 40 Suppl5: S373-S378.
  • Reimer J, Schulte B, Schaefer I, Backmund M, Haasen C (2005). Hepatitis C bei Drogengebrauchern. Suchttherapie; 6: 28-30.
  • Hedrich D, Schulte B, Reimer J (2004). Analyse der Leitlinien zur Hepatitis-C-Behandlung in den Ländern der Europäischen Union und Norwegen in Bezug auf den Behandlungszugang von DrogenkonsumentInnen. In: akzept, Deutsche Aidshilfe, LaBAS (Hrsg.): 1. Internationaler Fachtag Hepatitis C Berlin 2004. Innovative Konzepte und Praxis von Prävention und Psychosozialer Betreuung nach Drogengebrauch. Seiten 36-41. Berlin, akzept.
  • Reimer J, Schulte B, Haasen C, Krausz M (2004). Epidemiologie der Sucht. In: Backmund M (Hrsg.). Suchttherapie - Grundlagen, Klinik, Standards: Leitfaden für Praxis und Fortbildung. Seiten V1 - V11 (75 Seiten). Landsberg: Ecomed.